People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.

NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with…

This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013.

The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results.

A new method of scanning young cancer patients for tumours has been developed that avoids exposing them to potentially harmful radiation…

The brains of jazz musicians engrossed in spontaneous, improvisational musical conversation showed robust activation of brain areas traditionally…

London, 14 February 2014. 13:00 GMT: Norgine today announced that Luxembourg’s National Health Fund, the Caisse Nationale de Santé (CNS), has approved…

Imagine making an appointment to see an electrician. You talk to them about the layout of your house and the fact that you want modern, artistic lighting…

Psoralens + UVA (PUVA) therapy is a well-known treatment for vitiligo, as well as Narrowband-UVB (NB-UVB), but other photochemotherapy regimens for vitiligo